Effective February 9, 2017, if the recipient organization has submitted a renewal application on or before the date by which a Final Research Performance Progress Report (Final-RPPR) would be required for the current competitive segment, then submission of an "Interim-RPPR" via eRA Commons is now required. Based on this requirement, the NIH will discontinue the policy for renewal applications whereby, “whether funded or not,” the progress report contained in the renewal application may serve in lieu of a separate final progress report.
An Interim-RPPR link for the grant will appear in the Status tab in eRA Commons after the period of performance end date has passed. In the event that the renewal application is funded, NIH will treat the Interim-RPPR as the annual performance report for the final year of the previous competitive segment. If the renewal application is not funded, the Interim-RPPR will be treated by NIH staff as the institution's Final-RPPR.
As stated in NOT-OD-17-022, the Interim-RPPR must be submitted via the eRA Commons no later than 120 calendar days from the period of performance end date. If a recipient fails to comply with this reporting requirement, NIH may take one or more enforcement actions, such as a decision to withhold a non-competing continuation award, consistent with NIHGPS Chapter 8.5.2. NIH will maintain the business rule in the RPPR module enabling institutional signing officials (SOs), at their discretion, to delegate submission of the Final RPPR or Interim-RPPR to the Program Director/Principal Investigator (PD/PI).
Further guidance is provided through the scenarios below outlining the process of when to submit a Final or Interim-RPPR.
Status of Competing Renewal Application
Competing Renewal not submitted
Submit a Final-RPPR no later than 120 calendar days from the period of performance end date.
Competing Renewal submitted
Submit an Interim-RPPR no later than 120 calendar days from the period of performance end date. If the competing renewal is funded, NIH will treat the Interim-RPPR as the annual performance report for the final year of the previous competitive segment.
Competing Renewal submitted but not funded
Submit an Interim-RPPR no later than 120 calendar days from the period of performance end date. If the competing renewal is not funded, NIH will treat the Interim-RPPR as the institution's Final-RPPR. To reduce burden NIH will not require recipients to submit an additional Final-RPPR if the renewal application is not funded.
Reminder: Effective January 2017, NIH requires recipients to report on Project Outcomes in Section I of the Interim and Final-RPPR. Therefore, in each scenario listed above, Project Outcomes must be provided by the recipient in order for the recipient to submit their final report in eRA Commons. Otherwise, eRA Commons will not allow recipients to submit the required report and recipients will be considered non-compliant.
NOTE: Implementation of the Final RPPR for Small Business Innovation and Research (SBIR) and Small Business Technology Transfer (STTR) grants will occur approximately 2 months after implementation for all other NIH grants due to unique final reporting requirements under the Small Business Administration's SBIR/STTR Policy Directive.
NIH Notice NOT-OD-17-033 announces how Inauguration Day will affect deadlines that fall on Friday, January 20, as that is considered a Federal holiday for most NIH staff.
Please be aware and plan accordingly as NIH will have limited staffing on this date.
Impact on Support
• eRA Service Desk - open with reduced staffing
• General Grants Information support desk - unavailable
• Institute/Center staff - unavailable
Impact on Due Dates
• All application due dates that fall on January 20, 2017 will move to January 23, 2017, including (but not limited to) due dates for the following funding opportunity announcements:
o PAR-15-068 - NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34)
o RFA-CA-16-502 - Limited Competition: The Chernobyl Tissue Bank - Coordinating Center (U24)
Impact on Systems
• All eRA systems will remain operational
Please share this information with everyone (faculty, students/postdocs and staff) involved with grant proposal submissions or grant awards administration in your areas.
Should anyone have questions, please contact your assigned ORSP Grant Administrator or call 843-792-3838 for assistance.
NIH Notice NOT-OD-17-030 updates the NIH/AHRQ font guidance for applications due on or after January 25, 2017.
The Notice updates NIH’s recommended font list. Please note that NIH no longer requires that black text be used within grant application attachments.
For applications submitted for due dates on or after January 25, 2017, text in PDF attachments must follow these minimum requirements:
Since some PDF converters may reduce font size, it is important to confirm that the final PDF document complies with the font requirements.
The following fonts are recommended, although other fonts (both serif and non-serif) are acceptable if they meet the above requirements.
Legibility is of paramount importance. Applications that include PDF attachments that do not conform to the minimum requirements listed above may be withdrawn from consideration.